A trial looking at cediranib and chemotherapy for advanced cervical cancer (CIRCCa)

Overview

Cancer types:

Cervical cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at 2 chemotherapy drugs called carboplatin and paclitaxel alongside another drug called cediranib for cervical cancer. It was for women with cervical cancer that had spread or come back after treatment and couldn’t be removed with an operation. This trial was supported by Cancer Research UK.

Recruitment start: 19 August 2010

Recruitment end: 27 July 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Paul Symonds

Supported by

AstraZeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/10/001.

Last reviewed: 28 January 2016

CRUK internal database number: 4277

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.